Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 801–900 of 1,009
Terminal Alkyne-Modified DNA Aptamers with Enhanced Protein Binding Affinities
Kohn, E. M., Konovalov, K. A., Gomez, C. A., Hoover, G. N., Yik, A. K.-H., Huang, X., & Martell, J. D. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00183 · Cited by 20
Lovell, J. P., Bermea, K. C., Yu, J., Rousseau, S. T., Cohen, C. D., Bhalodia, A., Zita, M. D., Head, R. D., Blumenthal, R. S., Alharethi, R. A., et al. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.05.031 · Cited by 21
Sun, J., Xiang, J., An, Y., Xu, J., Xiong, Y., Wang, S., & Xia, Q. (2023) · Cancers · doi:10.3390/cancers15215147 · Cited by 18
Plasma Proteins Associated with Chronic Histopathologic Lesions on Kidney Biopsy
Kim, T., Surapaneni, A., Schmidt, I. M., Eadon, M. T., Kalim, S., Srivastava, A., Pálsson, R., Stillman, I. E., Hodgin, J. B., Menon, R., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000358 · Cited by 20
Elhadad, M. A., Gomez-Alonso, M. D. C., Chen, C., Neumeyer, S., Delerue, T., Rathmann, W., Näbauer, M., Meisinger, C., Kääb, S., Seißler, J., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02274-3 · Cited by 22
Current Readings: Blood-Based Biomarkers for Lung Cancer
Tsay, J.-C. J., DeCotiis, C., Greenberg, A. K., & Rom, W. N. (2013) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2013.11.001 · Cited by 19
Park, M., Vittinghoff, E., Ganz, P., Peralta, C. A., Whooley, M. A., & Shlipak, M. G. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301806 · Cited by 21
readat: An R package for reading and working with SomaLogic ADAT files
Cotton, R. J., & Graumann, J. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1007-8 · Cited by 18
Sperm cell purification from mock forensic swabs using SOMAmer™ affinity reagents
Katilius, E., Carmel, A. B., Koss, H., O'Connell, D., Smith, B. C., Sanders, G. M., & LaBerge, G. S. (2018) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2018.03.011 · Cited by 19
Self-citationHess, A. L., Carayol, J., Blædel, T., Hager, J., Cara, A. D., Astrup, A. V., Saris, W. H. M., Larsen, L. H., & Valsesia, A. (2018) · Genes & Nutrition · doi:10.1186/s12263-018-0597-3 · Cited by 19
Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage Fluid
DeBoer, E. M., Wagner, B. D., Popler, J., Harris, J. K., Zemanick, E. T., Accurso, F. J., Sagel, S. D., & Deterding, R. R. (2018) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800085 · Cited by 18
Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities
Ruiz-Lancheros, E., Chatelain, E., & Ndao, M. (2019) · Birkhäuser advances in infectious diseases · doi:10.1007/978-3-030-00054-7_16 · Cited by 18
Tsypin, M., Asmellash, S. G., Meyer, K. D., Touchet, B., & Röder, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226012 · Cited by 19
Oteng, E. K., Gu, W., & McKeague, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-66537-1 · Cited by 24
Uemachi, H., Kasahara, Y., Tanaka, K., Okuda, T., Yoneda, Y., & Obika, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060888 · Cited by 18
Proteomic Studies of Psoriasis
Соболев, В. В., Соболева, А. Г., Denisova, E. V., Pechatnikova, E. A., Dvoryankova, E. V., Korsunskaya, I. M., & Mezentsev, A. V. (2022) · Biomedicines · doi:10.3390/biomedicines10030619 · Cited by 20
Shubin, A. V., Kollár, B., Dillon, S. T., Pomahač, B., Libermann, T. A., & Riella, L. V. (2019) · Scientific Data · doi:10.1038/s41597-019-0324-y · Cited by 19
Proteomic Markers of Aging and Longevity: A Systematic Review
Kliuchnikova, A. A., Ilgisonis, E. V., Archakov, A. I., Ponomarenko, E. A., & Moskalev, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312634 · Cited by 21
Suppression of thrombospondin-1–mediated inflammaging prolongs hematopoietic health span
Ramalingam, P., Gutkin, M. C., Poulos, M. G., Winiarski, A., Smith, A., Carter, C., Doughty, C., Tillery, T., Redmond, D., Freire, A. G., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ads1556 · Cited by 17
Zhang, Z., Qian, H., Xu, R., Duan, Q., Wang, Y., Fu, T., Wu, X., Sha, C., Wu, Q., Wang, Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c11823 · Cited by 19
Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
Kindt, A. S. D., Förster, K. M., Otter, S. C. M. C.-D., Flemmer, A. W., Hauck, S. M., Flatley, A., Kamphuis, J., Karrasch, S., Behr, J., Franz, A. R., et al. (2022) · Pediatric Research · doi:10.1038/s41390-022-02093-w · Cited by 22
Takahashi, M. (2022) · Cells · doi:10.3390/cells11111825 · Cited by 17
Simple synthesis of massively parallel RNA microarrays via enzymatic conversion from DNA microarrays
Schaudy, E., Hölz, K., Lietard, J., & Somoza, M. M. (2022) · Nature Communications · doi:10.1038/s41467-022-31370-9 · Cited by 20
Prospects for the application of aptamer based assay platforms in pathogen detection
Banu, K., Mondal, B., Rai, B., Monica, N., & Hanumegowda, R. (2022) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2022.07.005 · Cited by 19
Liu, J., Nair, V., Zhao, Y., Chang, D., Limonte, C. P., Bansal, N., Fermin, D., Eichinger, F. H., Tanner, E. C., Bellovich, K. A., et al. (2022) · Diabetes · doi:10.2337/db22-0169 · Cited by 18
Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications
Li, Q., Zhou, L., Qin, S., Huang, Z., Li, B., Li, B., Yang, M., Nice, E. C., Zhu, H., & Huang, C. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115447 · Cited by 17
Shaping the future of oral cancer diagnosis: advances in salivary proteomics
Barros, O., D’Agostino, V., Santos, L. L., Vitorino, R. M. P., & Ferreira, R. M. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2343585 · Cited by 22
Puerta, R., Cano, A. C., García‐González, P., García‐Gutiérrez, F., Capdevila, M., de Rojas, I., Olivé, C., Blázquez-Folch, J., Sotolongo‐Grau, Ó., Miguel, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010286 · Cited by 20
Saloner, R., Staffaroni, A. M., Dammer, E. B., Johnson, E. C. B., Paolillo, E. W., Wise, A. B., Heuer, H. W., Forsberg, L. K., Lario‐Lago, A., Webb, J. D., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00878-2 · Cited by 24
DNA‐Assemblierung mittels Affinitätsbindung für die ultraempfindliche Proteindetektion
Zhang, H., Li, F., Dever, B., Wang, C., Li, X., & Le, X. C. (2013) · Angewandte Chemie · doi:10.1002/ange.201210022 · Cited by 17
Development of proteome‐wide binding reagents for research and diagnostics
Taussig, M., Schmidt, R., Cook, E. A., & Stoevesandt, O. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300060 · Cited by 18
Martin, J. A., Smith, J. E., Warren, M., Chávez, J. L., Hagen, J. A., & Kelley‐Loughnane, N. (2015) · Journal of Visualized Experiments · doi:10.3791/52545 · Cited by 17
Isotachophoresis-Enhanced Immunoassays: Challenges and opportunities
Khnouf, R., & Han, C. M. (2020) · IEEE Nanotechnology Magazine · doi:10.1109/mnano.2020.2966028 · Cited by 17
The separation sciences, the front end to proteomics: An historical perspective
Nice, E. C. (2020) · Biomedical Chromatography · doi:10.1002/bmc.4995 · Cited by 19
Le, A. T. H., Krylova, S. M., Beloborodov, S. S., Wang, T. Y., Hili, R., Johnson, P. E., Li, F., Veedu, R. N., Belyanskaya, S. L., & Krylov, S. N. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00601 · Cited by 17
Bonaroti, J. W., Billiar, I. M., Moheimani, H., Wu, J., Namas, R. A., Li, S. R., Kar, U. K., Yoram Vodovotz, B., Neal, M. D., Sperry, J. L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038086 · Cited by 18
Artificial Specific Binders Directly Recovered from Chemically Modified Nucleic Acid Libraries
Kasahara, Y., & Kuwahara, M. (2012) · Journal of Nucleic Acids · doi:10.1155/2012/156482 · Cited by 19
Spitsin, S. V., Tebas, P., Barrett, J. S., Pappa, V., Kim, D., Taylor, D. M., Evans, D. L., & Douglas, S. D. (2017) · JCI Insight · doi:10.1172/jci.insight.95893 · Cited by 19
Aptamers as the chaperones (Aptachaperones) of drugs-from siRNAs to DNA nanorobots
Citartan, M., Kaur, H., Presela, R., & Tang, T. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118483 · Cited by 17
Aptamer-capture based assays for human neutrophil elastase
Cheng, L., & Zhao, Q. (2012) · Talanta · doi:10.1016/j.talanta.2012.11.016 · Cited by 17
Plasma proteomic associations with Alzheimer’s disease endophenotypes
Afshar, S., Dammer, E. B., Bian, S., Bennett, D. A., Mohs, R. C., Beauregard, D., Dwyer, J. R., Hales, C. M., Goldstein, F. C., Parker, M. W., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00965-4 · Cited by 31
Genetic associations with micronutrient levels identified in immune and gastrointestinal networks
Morine, M. J., Monteiro, J. P., Wise, C., Teitel, C. H., Pence, L. M., Williams, A., Ning, B., McCabe‐Sellers, B., Champagne, C. M., Turner, J., et al. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0408-4 · Cited by 16
Circulating biomarkers in malignant pleural mesothelioma
Viscardi, G., Natale, D. D., Fasano, M., Brambilla, M., Lobefaro, R., Toma, A. D., & Galli, G. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00028 · Cited by 16
Muruve, D. A., Dêbiec, H., Dillon, S. T., Gu, X., Plaisier, E. M., Can, H., Otu, H. H., Libermann, T. A., & Ronco, P. M. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.04.006 · Cited by 18
Gudicha, D. W., Romero, R. J., Gomez‐Lopez, N., Galaz, J., Bhatti, G., Done, B., Jung, E., Gallo, D. M., Bosco, M., Suksai, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15392-3 · Cited by 17
SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients
Berrone, E., Chiorino, G., Guana, F., Benedetti, V., Palmitessa, C., Gallo, M., Calvo, A., Casale, F., Manera, U., Favole, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031899 · Cited by 16
Kalani, R., Bartz, T. M., Psaty, B. M., Elkind, M. S. V., Floyd, J. S., Gerszten, R. E., Shojaie, A., Heckbert, S. R., Bis, J. C., Austin, T. R., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207242 · Cited by 19
DiLillo, K. M., Norman, K. C., Freeman, C. M., Christenson, S. A., Alexis, N. E., Anderson, W. H., Barjaktarević, I., Barr, R. G., Comellas, A. P., Bleecker, E. R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32216-0 · Cited by 16
Comparative predictive power of serum vs plasma proteomic signatures in feto-maternal medicine
Espinosa, C. A., Ali, S. M., Khan, W., Khanam, R., Pervin, J., Price, J. T., Rahman, S., Hasan, T., Ahmed, S., Raqib, R., et al. (2023) · AJOG Global Reports · doi:10.1016/j.xagr.2023.100244 · Cited by 21
“sample costs for highly multiplexed proteomic analyses are several hundred dollars.(21,22) Consequently, biospecimens collected, made available, and analyzed through biobanking efforts should be of the highest possible scientific yield.”
BackgroundKimoto, M., Tan, H. P., Matsunaga, K., Mislan, N. A. B. M., Kawai, G., & Hirao, I. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c06122 · Cited by 17
Chen, T. K., Estrella, M. M., Appel, L. J., Surapaneni, A., Köttgen, A., Obeid, W., Parikh, C. R., & Grams, M. E. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.05.017 · Cited by 16
Circadian protein expression patterns in healthy young adults
Specht, A., Kolosov, G., Cederberg, K. L. J., Bueno, F. F., Arrona‐Palacios, A., Pardilla‐Delgado, E., Herrera, N. R., Zitting, K., Kramer, A., Zeitzer, J. M., et al. (2023) · Sleep Health · doi:10.1016/j.sleh.2023.10.005 · Cited by 18
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension
Rao, P., Keyes, M. J., Mi, M., Barber, J. L., Tahir, U. A., Deng, S., Clish, C. B., Shen, D., Farrell, L. A., Wilson, J. G., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.1397 · Cited by 20
Ahmadvand, D., Rahbarizadeh, F., & Moghimi, S. M. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.02.012 · Cited by 16
Emerging techniques employed in aptamer-based diagnostic tests
Yoshida, W., Abe, K., & Ikebukuro, K. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.868307 · Cited by 18
A proteomic signature that reflects pancreatic beta-cell function
Curran, A. M., Scott‐Boyer, M., Kaput, J., Ryan, M. F., Drummond, E. M., Gibney, E. R., Gibney, M. J., Roche, H. M., & Brennan, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202727 · Cited by 17
Label-free Detection of Dopamine Using Aptamer Enhanced Organic-Electrolyte Gated FET Sensor
Massey, R. S., Morin, E. L., DeRosa, M. C., & Prakash, R. (2019) · IEEE International Conference on Flexible and Printable Sensors and Systems (FLEPS) · doi:10.1109/fleps.2019.8792324 · Cited by 16
Phenotyping Angiotensin-Converting Enzyme in Blood: A Necessary Approach for Precision Medicine
Samokhodskaya, L. M., Jain, M., Kurilova, O. V., Bobkov, A. P., Kamalov, A. A., Dudek, S. M., & Danilov, S. M. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab032 · Cited by 14
Olson, N. C., Raffield, L. M., Moxley, A. H., Miller-Fleming, T. W., Auer, P. L., Franceschini, N., Ngo, D., Thornton, T. A., Lange, E. M., Li, Y., et al. (2021) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.121.003421 · Cited by 16
Le, A. T. H., Wang, T. Y., Krylova, S. M., Beloborodov, S. S., & Krylov, S. N. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04560 · Cited by 16
Pregnancy-specific responses to COVID-19 revealed by high-throughput proteomics of human plasma
Gomez‐Lopez, N., Romero, R. J., Escobar, M. F., Carvajal, J. A., Echavarría, M. P., Albornóz, L. L., Nasner, D., Miller, D., Gallo, D. M., Galaz, J., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00268-y · Cited by 19
Devices and approaches for generating specific high-affinity nucleic acid aptamers
Szeto, K., & Craighead, H. G. (2014) · Applied Physics Reviews · doi:10.1063/1.4894851 · Cited by 15
Jajack, A. J., Stamper, I., Gomez, E. F., Brothers, M. C., Begtrup, G., & Heikenfeld, J. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210286 · Cited by 16
Chen, J., & Zheng, N. (2020) · Bioanalysis · doi:10.4155/bio-2020-0198 · Cited by 17
Epigenetic scores for the circulating proteome as tools for disease predictionPreprint
Gadd, D. A., Hillary, R. F., McCartney, D. L., Zaghlool, S. B., Stevenson, A. J., Nangle, C., Campbell, A., Flaig, R., Harris, S. E., Walker, R. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.01.404681 · Cited by 15
Cross-platform proteomics to advance genetic prioritisation strategies
Pietzner, M., Wheeler, E., Carrasco-Zanini, J., Kerrison, N. D., Oerton, E., Koprulu, M., Luan, J., Hingorani, A. D., Williams, S. A., Wareham, N. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.18.435919 · Cited by 15
Shubin, N. J., Navalkar, K. A., Sampson, D. L., Yager, T. D., Cermelli, S., Seldon, T. A., Sullivan, E. M., Zimmerman, J. J., Permut, L. C., & Piliponsky, A. M. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004083 · Cited by 15
Schneider, D. J., Lynch, S. A., Gelinas, A. D., Ostroff, R. M., Rohloff, J. C., Williams, P., Janjić, N., & Drolet, D. W. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821595-1.00007-5 · Cited by 20
Self-citationKliuchnikova, A. A., Novikova, S. E., Ilgisonis, E. V., Kiseleva, O. I., Poverennaya, E. V., Zgoda, V. G., Moshkovskii, S. A., Poroikov, V., Lisitsa, A., Archakov, A. I., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010769 · Cited by 18
Success probability of high-affinity DNA aptamer generation by genetic alphabet expansion
Kimoto, M., Tan, H. P., Tan, Y. S., Mislan, N. A. B. M., & Hirao, I. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0031 · Cited by 15
Wang, L., Zhou, C., Zhang, W., Zhang, M., Cheng, W., & Feng, J. (2023) · Neurology · doi:10.1212/wnl.0000000000207408 · Cited by 17
Structure-Guided Development of Bivalent Aptamers Blocking SARS-CoV-2 Infection
Rahman, M. S., Han, M. J., Kim, S. W., Kang, S. M., Kim, B. R., Kim, H., Lee, C. J., Noh, J. E., Kim, H., Lee, J., et al. (2023) · Molecules · doi:10.3390/molecules28124645 · Cited by 18
Increasing the functional density of threose nucleic acid
Majumdar, B., Sarma, D., Yu, Y., Lozoya‐Colinas, A., & Chaput, J. C. (2024) · RSC Chemical Biology · doi:10.1039/d3cb00159h · Cited by 16
Porciani, D., Alampi, M. M., Abbruzzetti, S., Viappiani, C., & Delcanale, P. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c03341 · Cited by 16
Proteomics for heart failure risk stratification: a systematic review
Kuku, K. O., Oyetoro, R. O., Hashemian, M., Livinski, A. A., Shearer, J. J., Joo, J., Psaty, B. M., Levy, D. A., Ganz, P., & Roger, V. L. (2024) · BMC Medicine · doi:10.1186/s12916-024-03249-7 · Cited by 15
Non‐coding RNAs to treat vascular smooth muscle cell dysfunction
Brown, S., Klimi, E., Bakker, W. A. M., Beqqali, A., & Baker, A. H. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16409 · Cited by 18
A plasma protein-based risk score to predict hip fractures
Austin, T. R., Nethander, M., Fink, H. A., Törnqvist, A. E., Jalal, D. I., Bůžková, P., Barzilay, J. I., Carbone, L. D., Gabrielsen, M. E., Grahnemo, L., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00639-7 · Cited by 17
CSF Proteomics in Patients With Progressive Supranuclear Palsy
Wise, A. B., Li, J., Yamakawa, M., Loureiro, J., Peterson, B. K., Worringer, K. A., Sivasankaran, R., Palma, J., Mitic, L. L., Heuer, H. W., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209585 · Cited by 15
Aptamer based immunotherapy: a potential solid tumor therapeutic
Mathavan, S., Tam, Y., Mustaffa, K. M. F., & Tye, G. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1536569 · Cited by 21
Highly Multiplexed RNA Aptamer Selection using a Microplate-based Microcolumn Device
Reinholt, S. J., Ozer, A., Lis, J., & Craighead, H. (2016) · Scientific Reports · doi:10.1038/srep29771 · Cited by 11
Tanaka, K., Kasahara, Y., Miyamoto, Y., Takumi, O., Kasai, T., Onodera, K., Kuwahara, M., Oka, M., Yoneda, Y., & Obika, S. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob00706c · Cited by 15
Wasiak, S., Gilham, D., Daze, E., Tsujikawa, L. M., Halliday, C., Stotz, S. C., Rakai, B. D., Fu, L., Jahagirdar, R., Sweeney, M., et al. (2020) · Cardiovascular Therapeutics · doi:10.1155/2020/9397109 · Cited by 15
Uemachi, H., Kasahara, Y., Tanaka, K., Okuda, T., Yoneda, Y., & Obika, S. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104321 · Cited by 15
Xu, X., Zhang, C., Denton, D. T., O’Connell, D., Drolet, D. W., & Geisbrecht, B. V. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001260 · Cited by 19
Self-citationSmoking induces sex-specific changes in the small airway proteome
Kokelj, S., Östling, J., Georgi, B., Fromell, K., Ekdahl, K. N., Olsson, H., & Olin, A. (2021) · Respiratory Research · doi:10.1186/s12931-021-01825-6 · Cited by 19
Impact of severe hypoglycemia on the heat shock and related protein response
Atkin, A. S., Moin, A. S. M., Nandakumar, M., Al‐Qaissi, A., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-96642-8 · Cited by 17
Influenza A Virus Uses PSMA2 for Downregulation of the NRF2-Mediated Oxidative Stress Response
Rashid, M., Gao, A., & Coombs, K. M. (2022) · Journal of Virology · doi:10.1128/jvi.01990-21 · Cited by 17
Metformin for treatment of cytopenias in children and young adults with Fanconi anemia
Pollard, J. A., Furutani, E., Liu, S., Esrick, E. B., Cohen, L. E., Bledsoe, J. R., Liu, C., Lü, K., Ramírez, M. J., Surrallés, J., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006490 · Cited by 22
Zhang, Y., Ghose, U., Buckley, N. J., Engelborghs, S., Sleegers, K., Frisoni, G. B., Wallin, A., Lleó, A., Popp, J., Martínez‐Lage, P., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1040001 · Cited by 18
“SOMAscan is an aptamer-based platform which transforms individual protein signals into corresponding chemicallymodified nucleotide signals that can be quantified by relative fluorescence on DNA microarrays (Gold et al., 2010).”
BackgroundPatel, V., Dwivedi, A. K., Deodhar, S., Mishra, I., & Cistola, D. P. (2018) · Biomarker Research · doi:10.1186/s40364-018-0143-x · Cited by 15
Aptamer-modified Magnetic Nanosensitizer for in vivo MR imaging of HER2-expressing Cancer
Heo, D., Ku, M., Kim, J. H., Yang, J., & Suh, J. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2682-3 · Cited by 15
“In the case of the recently developed third-generation aptamers, they also have in vitro and in vivo stability due to their improved resistance against DNase or RNase by using modified nucleic acids [33, 34].”
BackgroundLe, A. T. H., Krylova, S. M., & Krylov, S. N. (2019) · Electrophoresis · doi:10.1002/elps.201900028 · Cited by 17
Le, A. T. H., Krylova, S. M., & Krylov, S. N. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01801 · Cited by 15
Rountree, W., Lynch, H. E., Denny, T. N., Sempowski, G. D., & Macintyre, A. N. (2024) · Journal of Immunological Methods · doi:10.1016/j.jim.2024.113699 · Cited by 14
Shimada, Y. J., Raita, Y., Liang, L. W., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003546 · Cited by 15
Njunge, J. M., Tickell, K. D., Diallo, A. H., Shahid, A. S. M. S. B., Gazi, M. A., Saleem, A. F., Kazi, Z., Ali, A., Tigoi, C., Mupere, E., et al. (2022) · Gates Open Research · doi:10.12688/gatesopenres.13635.1 · Cited by 18
Aptamer Technology and Its Applications in Bone Diseases
Liu, X., Hu, J., Ning, Y., Xu, H., Cai, H., Yang, A., Shi, Z.-S., & Li, Z. (2023) · Cell Transplantation · doi:10.1177/09636897221144949 · Cited by 18
de Bakker, M., Petersen, T. B., Akkerhuis, K. M., Harakaľová, M., Umans, V. A. W. M., Germans, T., Çalişkan, K., Katsikis, P. D., van der Spek, P. J., Suthahar, N., et al. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00516-9 · Cited by 15
The functional impact of rare variation across the regulatory cascade
Li, T., Ferraro, N. M., Strober, B. J., Aguet, F., Kasela, S., Arvanitis, M., Ni, B., Wiel, L., Hershberg, E. A., Ardlie, K., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100401 · Cited by 16
Adams, J. M., Rege, S. V., Liu, A. T., Vu, N. V., Raina, S., Kirsher, D. Y., Nguyen, A. L., Harish, R., Szoke, B. G., Leone, D. P., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf8764 · Cited by 18
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.